FDMT vs ROP · rev $37.0K vs P/E 41, rev $1.88B
4D Molecular Therapeutics Inc (FDMT) versus Roper Technologies, Inc. (ROP) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Roper Technologies, Inc. (ROP) is a software - application company listed on US.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
Latest reported ROP revenue for 2024-12-31 was $1.88B. Net income was $462.3M. Revenue was up 6.4% from 2024-09-30 to 2024-12-31. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
FDMT currently screens at market cap $518.1M. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
Not investment advice. Open the FDMT and ROP stock pages for the full models.
Not investment advice.